Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 123 clinical trials
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden

treatment of newly diagnosed high tumor burden non-Hodgkin's lymphoma, which has previously shown promising efficacy.

  • 26 Sep, 2021
  • 1 location
Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden

cell Non-Hodgkin's Lymphoma with hugh tumor burden (Sum of the Product of the perpendicular Diameters for multiple lesions, SPD 100cm^2 or the largest-diameter of tumor 10 cm.).

  • 26 Jan, 2021
  • 1 location
68Ga-PSMA PET/CT for Ra223 Assessment

between PET osseous tumor burden index and Alk-P level ii.The correlation between PET osseous tumor burden index and PSA level

  • 16 Mar, 2022
  • 1 location
HAI-Floxuridine or Liver-Tx Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Livermetasteses and Heavy Tumour Burden.

Patients with colorectal livermetasteses and heavy tumour burden and progression on 1st line chemotherapy have no other available treatment in Norway today other than 2nd line chemotherapy. The

  • 15 Jul, 2021
  • 1 location
18F-MFBG PET/CT in the Evaluation of Neuroendocrine Malignancies

The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with neuroendocrine

  • 14 Oct, 2021
  • 1 location
Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC

The hypothesis for this study is that addition of a moderate dose of radiotherapy to the primary tumor and mediastinal nodes after three months of medical treatment could reduce the tumor burden

stage iv non-small cell lung cancer
cancer chemotherapy
lung carcinoma
brain metastases
lung cancer
  • 24 Jan, 2021
  • 3 locations
RCT of CBD for Anxiety in Advanced Breast Cancer

tomography (CT) or positron emission tomography (PET) to assess tumor burden. The name of the study drug(s) are: Cannabidiol (CBD)

  • 26 Mar, 2022
  • 1 location
A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Copanlisib in Combination With Obinutuzumab in Patients With Previously Untreated Follicular Lymphoma (FL) and a High Tumor Burden (Alternative-C)

untreated follicular lymphoma (FL) and a high tumor burden. Additionally, the combination should be evaluated in terms of secondary efficacy endpoints, treatment compliance, safety and patient-reported

platelet count
measurable disease
follicular lymphoma
tumor burden
  • 03 Jun, 2022
  • 9 locations
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

Natural killer T (NKT) cells are a unique subset of lymphocytes that present a mixed T-NK phenotype. Our hypothesis is that Natural killer T cells may decrease the tumor burden and improve

solid tumor
serum bilirubin level
cancer chemotherapy
neutrophil count
lung carcinoma
  • 12 May, 2022
  • 2 locations
Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations

can allow for risk management and reduction with the overall goal of reducing cancer burden. Video-based intervention sent via text messages may help participants easily share information about BRCA

Accepts healthy volunteers
  • 11 Mar, 2022
  • 1 location